Dx Revision Watch
Suzy Chapman Owner of Dx Revision Watch
- Messages
- 3,061
- Location
- UK
As I asked in May 2009, when Dr Enlander announced his concept for a Journal called "Fatigue", "Where was the consultation?"
I was approached a few days ago by the organization and asked for my support and that any ideas and suggestions I might have to explain to patients and advocates how this new journal has the potential to advance the cause of CFS/ME would be welcomed.
My position is that I cannot support the concept for this journal.
[My highlighting]
Journal website links:
http://www.tandf.co.uk/journals/journal.asp?issn=2164-1846&linktype=1
http://www.tandf.co.uk/journals/journal.asp?issn=2164-1846&linktype=44
http://www.tandf.co.uk/journals/authors/rftg-article-types.pdf
---------------------------------------------------
http://iacfsme.org/Portals/0/pdf/IACFSMEJournal_Letter_to_Membership_final.pdf
New IACFS/ME Fatigue Journal
Dear Members and Colleagues,
On behalf of the board of directors of the International Association
for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME), I
have signed a contract with a major academic publisher
(Routledge/Taylor and Frances) to launch a new subscription-based peer
review journal titled: Fatigue: Biomedicine, Health and Behavior. This
will be a quarterly publication with the inaugural issue scheduled for
release in January, 2013. There are no publication fees for authors.
CFS/ME and the New Journal
The mission of the IACFS/ME is to promote, stimulate and coordinate
the exchange of ideas related to CFS, ME, and fibromyalgia (FM)
research, patient care and treatment. The board of directors believes
that these challenging medical conditions will benefit from a journal
that, while continuing to support research on CFS/ME and FM, also
encourages thinking outside the box of a particular disease or
condition.
In support of this idea, major advances in biomedicine have more often
evolved from broad cross-disciplinary collaborations in comparison to
the efforts of a single research laboratory. One example: large scale
collaborations produced the central sensitization model of pain in FM
and other pain conditions -- which has led to new, more effective
medications for pain.
Consistent with this multidisciplinary approach, our new journal
welcomes all fatigue-related research and clinical approaches to the
treatment of this often debilitating symptom. Scientific papers on all
aspects of CFS/ME are particularly encouraged and will be published in
this new journal. We view side-by-side articles on CFS/ME and other
fatiguing illnesses as facilitating comparisons and collaborative
discussions that could generate innovative thinking and new directions
in research.
In addition to collaborations, the journal can better legitimize
CFS/ME by demonstrating that the life-altering fatigue symptoms found
in well-recognized illnesses such as cancer and MS are also a core
feature of CFS/ME. Rather than trivialization of fatigue as a clinical
entity, our journal intends to elevate the symptom of fatigue to an
important research focus and medical concern. Secondly, by publishing
a journal that encompasses a larger biomedical domain, fatigue
researchers and practicing clinicians unfamiliar with CFS/ME and FM
will have greater exposure to these understudied conditions in a high
credibility publication: a scientific peer review journal.
A Brief History
Unfortunately, a CFS/ME-dedicated journal is no longer a viable
enterprise. The Journal of Chronic Fatigue Syndrome (JCFS) folded in
2008 in part because it attracted only 400 subscribers worldwide and
was never indexed on Medline. (If permitted by the past publisher,
electronic copies of JCFS will be made available on the IACFS/ME
website.) Our new journal is intended to succeed based on its broad
multidisciplinary focus, eventual Medline listing, and its backing by
a major academic publisher.
This new journal contract is the result of four years of proposals,
conferences, and negotiations with a number of academic publishers.
Gudrun Lange, PhD, a former board member and editor of the IACFS/ME
Bulletin, played an important role in bringing about this new journal.
The entire board of directors is to be commended for facilitating this
new endeavor.
The First Fatigue Journal
Fatigue will be the first biomedical and behavioral journal focused on
fatigue. We believe that high quality contributions in the area of
fatigue are more likely to be submitted to a journal that clearly
recognizes the importance of fatigue as a field of scientific study as
well as a significant clinical concern. Not infrequently, submitted
papers on fatigue (including CFS/ME) are not even sent out for review
as editors often view fatigue as outside the purview of their
journal’s mission. This is understandable given that no medical
journal has a primary focus on fatigue.
In a sense, this new publication will be a prominent vehicle to
further advance fatigue as an important field of study. Given that
fatigue focused peer review articles have increased almost 100% over
the past decade (>1000 published papers in 2011 alone), we expect to
attract some proportion of these papers to our journal. With the
guidance of our publisher, we plan to apply for Medline indexing when
acceptance is likely. The publisher will promote, market, and
advertise the journal to medical libraries, conferences, and other
professional events worldwide.
Journal Aim and Content
Our aim for the new journal is to address the symptom of fatigue in
medical illnesses, behavioral disorders, and specific environmental
conditions. These broadly conceived domains, all housed in one
journal, are intended to advance interdisciplinary research on
causation, pathophysiology, assessment, diagnosis, and treatment. The
content that we seek includes original research papers, literature
reviews, data-based theoretical papers, short reports, qualitative
studies, case studies, conference reports, expert interactive
commentary, and letters to the editor.
The list of topics covered in Fatigue will encompass: fatigue in
diseases including cancer, autoimmune diseases, CFS/ME, multiple
sclerosis (MS), pain conditions, mood disorders, and circulatory
diseases. In addition, specific issues involving fatigue in sleep,
aging, exercise and sport, and occupations will be addressed. More
generally, the journal will publish on the biology, physiology and
psychosocial aspects of fatigue as well as diagnosis and treatment.
We also welcome new topics such as clinical fatigue education in
medical schools and public health policy with respect to fatigue.
Ultimately, we plan to develop dedicated sections of the journal for
specific research and clinical areas such as cancer and MS fatigue,
CFS/ME, fatigue and sleep, fatigue and exercise, fatigue and aging,
occupational fatigue and athletic /sports fatigue.
Distinguished Editorial Board
As an international journal, we have assembled a distinguished
editorial board of fatigue scientists and clinicians from North
America, Europe and Asia (Japan has its own professional fatigue
society). The journal will be administered by the IACFS/ME through the
journal editor (Friedberg), editorial board, and the editorial staff
with an internet-based submission and review process. Our peer review
will be a continuation of the procedures used in our current journal,
Bulletin of the IACFS/ME, which will cease publication after a final
issue this summer. All past issues of the Bulletin will continue to be
available on the IACFS/ME website.
Submissions Now Accepted
We have begun accepting manuscript submissions for next year’s
start-up issues. If you would like to be part of this new endeavor, we
welcome your submission. The journal’s new website (under development)
now contains author instructions and submission information:
www.tandfonline.com/rftg
With best regards,
Fred
Fred Friedberg, PhD
President
International Association for Chronic Fatigue Syndrome/Myalgic
Encephalomyelitis (IACFS/ME)
www.iacfsme.org
Editor
Fatigue: Biomedicine, Health and Behavior
Journal website (under development): www.tandfonline.com/rftg
Email: Fred.Friedberg@stonybrookmedicine.edu
Research Associate Professor
Putnam Hall/South Campus
Stony Brook University
Stony Brook, New York 11794-8790
USA
-------------------------
I was approached a few days ago by the organization and asked for my support and that any ideas and suggestions I might have to explain to patients and advocates how this new journal has the potential to advance the cause of CFS/ME would be welcomed.
My position is that I cannot support the concept for this journal.
[My highlighting]
Journal website links:
http://www.tandf.co.uk/journals/journal.asp?issn=2164-1846&linktype=1
http://www.tandf.co.uk/journals/journal.asp?issn=2164-1846&linktype=44
http://www.tandf.co.uk/journals/authors/rftg-article-types.pdf
---------------------------------------------------
http://iacfsme.org/Portals/0/pdf/IACFSMEJournal_Letter_to_Membership_final.pdf
New IACFS/ME Fatigue Journal
Dear Members and Colleagues,
On behalf of the board of directors of the International Association
for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME), I
have signed a contract with a major academic publisher
(Routledge/Taylor and Frances) to launch a new subscription-based peer
review journal titled: Fatigue: Biomedicine, Health and Behavior. This
will be a quarterly publication with the inaugural issue scheduled for
release in January, 2013. There are no publication fees for authors.
CFS/ME and the New Journal
The mission of the IACFS/ME is to promote, stimulate and coordinate
the exchange of ideas related to CFS, ME, and fibromyalgia (FM)
research, patient care and treatment. The board of directors believes
that these challenging medical conditions will benefit from a journal
that, while continuing to support research on CFS/ME and FM, also
encourages thinking outside the box of a particular disease or
condition.
In support of this idea, major advances in biomedicine have more often
evolved from broad cross-disciplinary collaborations in comparison to
the efforts of a single research laboratory. One example: large scale
collaborations produced the central sensitization model of pain in FM
and other pain conditions -- which has led to new, more effective
medications for pain.
Consistent with this multidisciplinary approach, our new journal
welcomes all fatigue-related research and clinical approaches to the
treatment of this often debilitating symptom. Scientific papers on all
aspects of CFS/ME are particularly encouraged and will be published in
this new journal. We view side-by-side articles on CFS/ME and other
fatiguing illnesses as facilitating comparisons and collaborative
discussions that could generate innovative thinking and new directions
in research.
In addition to collaborations, the journal can better legitimize
CFS/ME by demonstrating that the life-altering fatigue symptoms found
in well-recognized illnesses such as cancer and MS are also a core
feature of CFS/ME. Rather than trivialization of fatigue as a clinical
entity, our journal intends to elevate the symptom of fatigue to an
important research focus and medical concern. Secondly, by publishing
a journal that encompasses a larger biomedical domain, fatigue
researchers and practicing clinicians unfamiliar with CFS/ME and FM
will have greater exposure to these understudied conditions in a high
credibility publication: a scientific peer review journal.
A Brief History
Unfortunately, a CFS/ME-dedicated journal is no longer a viable
enterprise. The Journal of Chronic Fatigue Syndrome (JCFS) folded in
2008 in part because it attracted only 400 subscribers worldwide and
was never indexed on Medline. (If permitted by the past publisher,
electronic copies of JCFS will be made available on the IACFS/ME
website.) Our new journal is intended to succeed based on its broad
multidisciplinary focus, eventual Medline listing, and its backing by
a major academic publisher.
This new journal contract is the result of four years of proposals,
conferences, and negotiations with a number of academic publishers.
Gudrun Lange, PhD, a former board member and editor of the IACFS/ME
Bulletin, played an important role in bringing about this new journal.
The entire board of directors is to be commended for facilitating this
new endeavor.
The First Fatigue Journal
Fatigue will be the first biomedical and behavioral journal focused on
fatigue. We believe that high quality contributions in the area of
fatigue are more likely to be submitted to a journal that clearly
recognizes the importance of fatigue as a field of scientific study as
well as a significant clinical concern. Not infrequently, submitted
papers on fatigue (including CFS/ME) are not even sent out for review
as editors often view fatigue as outside the purview of their
journal’s mission. This is understandable given that no medical
journal has a primary focus on fatigue.
In a sense, this new publication will be a prominent vehicle to
further advance fatigue as an important field of study. Given that
fatigue focused peer review articles have increased almost 100% over
the past decade (>1000 published papers in 2011 alone), we expect to
attract some proportion of these papers to our journal. With the
guidance of our publisher, we plan to apply for Medline indexing when
acceptance is likely. The publisher will promote, market, and
advertise the journal to medical libraries, conferences, and other
professional events worldwide.
Journal Aim and Content
Our aim for the new journal is to address the symptom of fatigue in
medical illnesses, behavioral disorders, and specific environmental
conditions. These broadly conceived domains, all housed in one
journal, are intended to advance interdisciplinary research on
causation, pathophysiology, assessment, diagnosis, and treatment. The
content that we seek includes original research papers, literature
reviews, data-based theoretical papers, short reports, qualitative
studies, case studies, conference reports, expert interactive
commentary, and letters to the editor.
The list of topics covered in Fatigue will encompass: fatigue in
diseases including cancer, autoimmune diseases, CFS/ME, multiple
sclerosis (MS), pain conditions, mood disorders, and circulatory
diseases. In addition, specific issues involving fatigue in sleep,
aging, exercise and sport, and occupations will be addressed. More
generally, the journal will publish on the biology, physiology and
psychosocial aspects of fatigue as well as diagnosis and treatment.
We also welcome new topics such as clinical fatigue education in
medical schools and public health policy with respect to fatigue.
Ultimately, we plan to develop dedicated sections of the journal for
specific research and clinical areas such as cancer and MS fatigue,
CFS/ME, fatigue and sleep, fatigue and exercise, fatigue and aging,
occupational fatigue and athletic /sports fatigue.
Distinguished Editorial Board
As an international journal, we have assembled a distinguished
editorial board of fatigue scientists and clinicians from North
America, Europe and Asia (Japan has its own professional fatigue
society). The journal will be administered by the IACFS/ME through the
journal editor (Friedberg), editorial board, and the editorial staff
with an internet-based submission and review process. Our peer review
will be a continuation of the procedures used in our current journal,
Bulletin of the IACFS/ME, which will cease publication after a final
issue this summer. All past issues of the Bulletin will continue to be
available on the IACFS/ME website.
Submissions Now Accepted
We have begun accepting manuscript submissions for next year’s
start-up issues. If you would like to be part of this new endeavor, we
welcome your submission. The journal’s new website (under development)
now contains author instructions and submission information:
www.tandfonline.com/rftg
With best regards,
Fred
Fred Friedberg, PhD
President
International Association for Chronic Fatigue Syndrome/Myalgic
Encephalomyelitis (IACFS/ME)
www.iacfsme.org
Editor
Fatigue: Biomedicine, Health and Behavior
Journal website (under development): www.tandfonline.com/rftg
Email: Fred.Friedberg@stonybrookmedicine.edu
Research Associate Professor
Putnam Hall/South Campus
Stony Brook University
Stony Brook, New York 11794-8790
USA
-------------------------